Identification of mechanism(s) of miRNA- mediated repression of translation

Lead Research Organisation: MRC Toxicology Unit
Department Name: MRC Toxicology Unit

Abstract

Recently, a completely new way of controlling gene expression has been identified. This has come to light after the discovery of a whole new class of genes comprising very small RNA molecules, that unlike most genes do not produce proteins. There are at least 800 of these small RNA molecules within the human genome which have different effects. They work by binding to the mRNA of other genes and inhibiting the target genes from being made into proteins. Each of these 800 small molecules is believed to interact with 100 other genes, thus adding to the complexity of the regulation of the human genome. Already it has become clear that malfunction of miRNA regulation is associated with a growing list of human disease, including: cancer; diabetes; and viral infections. In 2002 Science magazine called miRNA the breakthrough of the year and these small RNA molecular have been termed the 'Dark Matter of the cell'. At present there is great controversy within the scientific community over how these small RNA molecules repress gene expression. Laboratories around the world have shown conflicting data for how this repression mechanism functions, and have failed to reproduce each other's data. We have, for the first time, been able to shown both repression mechanisms operating and determined how these difference are occurring. We are now in a unique position to investigate the different mechanisms and to determine which genes are regulated by the different repression systems. This will lead to a great impact on the way in which we understand gene expression and the complexity of the human genome.

Technical Summary

microRNAs comprise of 2-3% of the cellular genome and exert their phenotype influence via interacting with imperfect complementary to the 3`untranslated regions (UTR) of mRNAs. It has been suggested that between 74-92% of mRNAs are regulated by microRNAs. The mechanisms of regulation appear to occur primarily at the level of translation. However there is a dispute in the field about the mechanism(s) used to achieve miRNA-mediated repression with data from some laboratories suggesting a block at translation initiation whilst other data strongly showing a post-initiation inhibition. We have been able to show that the promoter element dictates whether the repression mechanisms occur at the level of initiation or post initiation. We are now in a unique position to investigate both the factors which mediate this types of regulation and which genes are controlled by the two different mechanisms.

Publications

10 25 50
publication icon
Fonseca BD (2014) The ever-evolving role of mTOR in translation. in Seminars in cell & developmental biology

publication icon
Kong YW (2012) microRNAs in cancer management. in The Lancet. Oncology

publication icon
Wilczynska A (2015) The complexity of miRNA-mediated repression. in Cell death and differentiation

 
Description Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, Godfrey JD, Willis AE, Bushell M*. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science, 2013, 340:82-5.
First description of the central role of a DEAD-box RNA helicase in miRNA-mediated repression. We demonstrated that translation repression is a prerequisite to subsequent mRNA decay. 5'UTR structure was shown to correlate with presence of miRNA target sites within the 3'UTR of an mRNA.
Exploitation Route We are still investigating outputs from this award. This has led to drug discovery activities in this area with Cancer Research Technology
Sectors Pharmaceuticals and Medical Biotechnology

 
Description Only for basic understand research application so far
Sector Pharmaceuticals and Medical Biotechnology
 
Description CRT translational control allience
Amount £23,000,000 (GBP)
Organisation Cancer Research Technology (CRT) 
Sector Private
Country United Kingdom
Start 06/2018 
End 06/2021
 
Description New therapeutic strategy to specifically target the oncogenic function of eukaryotic translation initiation factor 4A1
Amount £296,000 (GBP)
Funding ID C20673/A30062 
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2020 
End 02/2023
 
Description Research collaboration resulting in a BBSRC grant 
Organisation Medical Research Council (MRC)
Department MRC Centre for Obesity and Related Metabolic Diseases
Country United Kingdom 
Sector Academic/University 
PI Contribution I was a co-PI on this two site award
Collaborator Contribution This award is a joint proposal and split 50/50
Impact 2 BBSRC grants 2 research papers
Start Year 2006
 
Description Invited Speaker Sussex Univ 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Invited speaker at Sussex University. Gave a talk on translation control and changed the way people think about this level of gene expression control
Year(s) Of Engagement Activity 2019
 
Description Invited Speaker Wurburg 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Invited speaker in Wurzburg Germany. I gave a talk to science in the area and got great feedback and changed the way they think about translational control
Year(s) Of Engagement Activity 2020
 
Description Invited speaker Dundee 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Professional Practitioners
Results and Impact Invited speaker at the University of Dundee. Gave a talk on translational control and changed the way they think about this level of gene expression control.
Year(s) Of Engagement Activity 2019
 
Description Invited speaker Galway 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Invited speaker Galway Ireland. Gave a talk on translational control and changed the way they think about this level of gene regulation.
Year(s) Of Engagement Activity 2019
 
Description Organiser for Beatson International Science Meeting 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact I was one of the organisers for this meeting which brought in people from all over the world to talk about their recent results. One of the sessions was focused on translational control which I run and talked in.
Year(s) Of Engagement Activity 2019
 
Description Translation UK 2020 organiser 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact This is a major meeting for the whole field and occurs yearly. I was an organiser for this meeting. Importantly this year we had a large number of people from industry activity developing drugs to target this field and they sponsored this meeting and chaired a session. Got great feed back about this meeting and how good it was. This was organiser by the biochem doc.
Year(s) Of Engagement Activity 2019